Cited by 93Bipolar Disorder and TreatmentEpigenetics and DNA MethylationGenomics and Chromatin Dynamics

H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression

Open access
Cruceanu, Cristiana, Alda, Martin, Nagy, Corina, Freemantle, Erika, Rouleau, Guy A., Turecki, Gustavo·2013·International Journal of Neuropsychopharmacology

Abstract

The synapsin family of neuronal phosphoproteins is composed of three genes (SYN1, SYN2 and SYN3) with alternative splicing resulting in a number of variants with various levels of homology. These genes have been postulated to play significant roles in several neuropsychiatric disorders, including bipolar disorder, schizophrenia and epilepsy. Epigenetic regulatory mechanisms, such as histone modifications in gene regulatory regions, have also been proposed to play a role in a number of psychiatric disorders, including bipolar disorder and major depressive disorder. One of the best characterized histone modifications is histone 3 lysine 4 tri-methylation (H3K4me3), an epigenetic mark shown to be highly enriched at transcriptional start sites and associated with active transcription. In the present study we have quantified the expression of transcript variants of the three synapsin genes and investigated their relationship to H3K4me3 promoter enrichment in post-mortem brain samples. We found that histone modification marks were significantly increased in bipolar disorder and major depression and this effect was correlated with significant increases in gene expression. Our findings suggest that synapsin dysregulation in mood disorders is mediated in part by epigenetic regulatory mechanisms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145712000363

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Case/control differences in histone acetylation and methylation have been observed in depression.

    “Like with DNAm, case/control differences in depression have been observed.”

    From Epigenetics and depression (2019) · cites this paper as [20]

    The SYN2 expression section reports greater H3K4me3 enrichment at the SYN1 promoter in the major-depression group, supporting a case/control difference in histone methylation. The Discussion says the study investigated only one epigenetic modification; it does not report a case/control difference in histone acetylation. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Enhancement of H3K4me3 was found in postmortem brain tissue BA10 in MDD, enriched at transcriptional start sites of synapsin 1 and relevant to increased expression of synapsin 1a and synapsin 1b.

    “enhancement of H3K4me3 was found in postmortem brain tissue (BA10) in MDD165: the enriched H3K4me3 was found at transcriptional start sites of synapsin 1, relevant to increased expression of synapsin 1a and synapsin 1b.”

    From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [165]

    The results section on H3K4me3 enrichment (page not supplied) reports enrichment at the shared SYN1a/SYN1b promoter in MDD, and the expression results report increased expression of both variants in MDD. The tissue was post-mortem BA10. But the paper found no significant correlation between SYN1 expression and H3K4me3 enrichment, so it does not support the implied link between them. (LLM, conf=0.91)

    Experimental — accuracy not yet measured
  • Enrichment of trimethylated H3K4 at the SYN1 promoter was reported in postmortem prefrontal cortex of MDD patients.

    “Another study of histone modifications in postmortem prefrontal cortex (PFC) of MDD patients reported enrichment of trimethylated H3K4—a modification generally associated with transcriptional activity—at the SYN1 promoter.”

    From Epigenetics and depression (2019) · cites this paper as [20]

  • Variable H3-K4 methylation of synapsin genes has been shown to give rise to altered expression patterns in bipolar disorder and major depression.

    “Variable H3-K4 methylation of synapsin genes has been shown to give rise to altered expression patterns in bipolar disorder and major depression29”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cruceanu, C., Alda, M., Nagy, C., Freemantle, E., Rouleau, G. A., & Turecki, G.
Affiliations
  • Douglas Mental Health University Institute (CA)
  • Dalhousie University (CA)
  • Centre Hospitalier de l’Université de Montréal (CA)
Corresponding author
Turecki, Gustavo
Venue
International Journal of Neuropsychopharmacology
Published
2012-05-09
Volume
16
Issue
2
Pages
289-299
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2140687548
Cited by
93
References
62
Citations by year
2026: 3 · 2025: 5 · 2024: 9 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 10 · 2014: 9 · 2013: 2 · 2012: 2
FWCI
5.24
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
Canadian Institutes of Health Research (64410)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
synapsin, synapsin I, alternative splicing, splice variants, histone modifications, epigenetic regulation, bipolar disorder, major depressive disorder, mood disorders, postmortem brain, gene expression
MeSH terms
Histone Methyltransferases, Adult, Analysis of Variance, Bipolar Disorder, Brain, Major Depressive Disorder, Female, Histones, Humans, Male, Methylation, Middle Aged, Probability, Promoter Regions, Genetic, Histone-Lysine N-Methyltransferase, Statistics as Topic, Gene Expression, Synapsins, Epigenesis, Genetic, Chromatin Immunoprecipitation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review